Carrie D'Andrea
Chief Tech/Sci/R&D Officer en ACASTI PHARMA INC. .
Fortuna: - $ al 31/03/2024
Perfil
Carrie D'Andrea is currently the Vice President-Clinical Operations at Acasti Pharma, Inc. She previously held the same position at Edge Therapeutics, Inc. from 2014 to 2019 and at EryDel SpA from 2020 to 2021.
She is a graduate of Temple University (Pennsylvania).
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 06/05/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Carrie D'Andrea
| Empresas | Cargo | Inicio |
|---|---|---|
| ACASTI PHARMA INC. | Chief Tech/Sci/R&D Officer | 08/05/2023 |
Antiguos cargos conocidos de Carrie D'Andrea.
| Empresas | Cargo | Fin |
|---|---|---|
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Corporate Officer/Principal | 01/04/2021 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Chief Tech/Sci/R&D Officer | 01/03/2019 |
Formación de Carrie D'Andrea.
| Temple University (Pennsylvania) | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ACASTI PHARMA INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
- Bolsa de valores
- Insiders
- Carrie D'Andrea
